基本信息
浏览量:156
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Sakamoto’s research has focused on signaling pathways and gene regulation in normal and aberrant hematopoiesis, including leukemia and bone marrow failure syndromes. She is specifically interested in targeted therapies for leukemia and other types of pediatric cancers. Dr. Sakamoto has been funded by the National Institutes of Health for 28 years. She currently holds the Shelagh Galligan Endowed Professorship and has received awards from the American Cancer Society, Leukemia & Lymphoma Society, Bear Necessities, and CDMRP(DOD). She is developing novel therapies to target CREB for the treatment of acute leukemia and bone marrow failure syndromes. Promising small molecule compounds that are effective in the lab and nontoxic will be tested and optimized to take to the clinic for patients with relapsed leukemia and Diamond Blackfan Anemia. This will provide novel approaches to treat leukemia in children.
研究兴趣
论文共 260 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current oncology reportsno. 3 (2024): 250-257
Current Oncology Reportsno. 3 (2024): 250-257
Stem Cellsno. 6 (2023): 560-569
Journal for immunotherapy of cancerno. 5 (2023): e006649-e006649
Y. Lucy Liu,Nan Wang, Nicholas Neoman,Carolyn Wong,Bertil Glader,Raymond T. Doty,Mark C Wilkes,Janis L. Abkowitz,Kathleen M. Sakamoto
Blood (2023): 944
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn